Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fusion proteins from artificial and natural structural modules.

N Liu1, G Caderas, C Deillon

  • 1Biochemisches Institut der Universität Zürich, Winterthurerstrasse 190, Switzerland.

Current Protein & Peptide Science
|October 9, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design of catalytic polypeptides and proteins.

Protein engineering, design & selection : PEDS·2019
Same author

Downregulation of PCK2 remodels tricarboxylic acid cycle in tumor-repopulating cells of melanoma.

Oncogene·2017
Same author

[PTPS gene analysis and prenatal diagnosis in patients with 6-pyruvoyl-tetra hydropterin synthase deficiency].

Zhonghua fu chan ke za zhi·2017
Same author

[Mutation analysis for two hypophosphatasia families with targeted next-generation sequencing].

Zhonghua yi xue za zhi·2016
Same author

RNA interference unveils the importance of Pseudotrichonympha grassii cellobiohydrolase, a protozoan exoglucanase, in termite cellulose degradation.

Insect molecular biology·2016
Same author

[<i>PAX3</i> gene mutation analysis for two Waardenburg syndrome type Ⅰ families and their prenatal diagnosis].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2016
Same journal

Therapeutic Peptides as Targeting Vectors and Smart Therapeutics: Emerging Trends and Future Perspectives.

Current protein & peptide science·2026
Same journal

Innovative Protein Nanostructures and Hybrid Systems for Enhanced Encapsulation and Controlled Delivery of Bioactive Agents.

Current protein & peptide science·2026
Same journal

Nanotherapeutic Interventions in Diabetic Wound Healing: Biomarker- Guided Mechanisms and Translational Prospects.

Current protein & peptide science·2026
Same journal

Recent developments in intein-mediated protein splicing and their applications in bioengineering.

Current protein & peptide science·2026
Same journal

Amyloids of Food Proteins: Balancing Benefits and Risks.

Current protein & peptide science·2026
Same journal

Phosphodiesterase-5 Inhibitors in Neurodegenerative Diseases: A Path to Cognitive Rescue.

Current protein & peptide science·2026
See all related articles

Fusion proteins enhance stability and biological activity, aiding in protein engineering and therapeutic development. This includes improving enzyme function and creating novel DNA-binding proteins with specific activities.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Protein Engineering

Background:

  • Fusion proteins are engineered molecules combining genetic sequences to achieve desired structural and functional properties.
  • Natural and designed sequences are utilized to create fusion proteins with enhanced stability and modified biological activities.
  • Examples include enhancing intracellular stability and enzymatic activity, and creating novel DNA-binding proteins.

Purpose of the Study:

  • To explore the dual purpose of preparing fusion proteins: structural stabilization and biological activity modification.
  • To investigate the role of specific fusion partners, such as beta-galactosidase and leucine zippers, in altering protein characteristics.
  • To examine the utility of leader sequences in protein translocation and the formation of novel protein structures.

Related Experiment Videos

Main Methods:

  • Fusion of designed peptides with beta-galactosidase to enhance stability and DDT-degrading activity.
  • Construction of fusion proteins with leucine zippers to create mono- and bifunctional antibody fragments and DNA-binding proteins.
  • Engineering of an artificial homodimeric HIV-1 enhancer-binding protein with increased specificity.
  • Investigating the role of leader sequences in protein translocation across cellular membranes.
  • Characterization of a retro-leucine zipper formed as a byproduct of dimerization.

Main Results:

  • Fusion with beta-galactosidase increased intracellular stability and DDT-degrading activity of a designed peptide.
  • Leucine zipper fusions yielded mono- and bifunctional single-chain variable domain antibody fragments.
  • Engineered homodimeric and heterodimeric DNA-binding proteins, including an HIV-1 enhancer-binding protein with enhanced specificity and repressor activity.
  • Identified short leader sequences mediating protein translocation across membranes.
  • Synthesized and characterized a retro-leucine zipper as an unexpected outcome.

Conclusions:

  • Fusion protein technology offers a versatile approach for protein stabilization and functional modulation.
  • Specific fusion partners and leader sequences can be strategically employed to enhance protein performance and localization.
  • The study highlights the potential of protein engineering for developing novel biomolecules with tailored properties, including therapeutic applications.